During the past 12 months, Baotou Dongbao Bio-Tech Co's average Total Assets Growth Rate was 6.00% per year.
During the past 3 years, the average Total Assets Growth Rate was 3.50% per year.
During the past 5 years, the average Total Assets Growth Rate was 11.30% per year.
During the past 10 years, the average Total Assets Growth Rate was 17.20% per year.
During the past 13 years, Baotou Dongbao Bio-Tech Co's highest 3-Year average Total Assets Growth Rate was 28.00%. The lowest was 3.50%. And the median was 18.50%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baotou Dongbao Bio-Tech Co Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baotou Dongbao Bio-Tech Co (SZSE:300239) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2025) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Baotou Dongbao Bio-Tech Co's Asset Turnover for the quarter that ended in Mar. 2025 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Baotou Dongbao Bio-Tech Co Total Assets Related Terms
Thank you for viewing the detailed overview of Baotou Dongbao Bio-Tech Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Baotou Dongbao Bio-Tech Co Ltd operates in pharmaceutical manufacturing industry. The products of the company include collage, photosensitive gelatin, medicinal gelatin, edible gelatin, and calcium hydrogen phosphate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300239 has been successfully added to your 